Fidia S.p.A. (BIT:FDA)
| Market Cap | 4.20M +31.7% |
| Revenue (ttm) | 30.56M +74.3% |
| Net Income | 1.04M |
| EPS | 0.00 |
| Shares Out | 499.41M |
| PE Ratio | 2.80 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 995,000 |
| Open | 0.0084 |
| Previous Close | 0.0084 |
| Day's Range | 0.0084 - 0.0088 |
| 52-Week Range | 0.0030 - 0.3050 |
| Beta | 0.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, production and sale of numerical controls and software, high-speed milling systems and after-sales technical assistance. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions incl... [Read more]
Financial Performance
Financial StatementsNews
Sagimet Biosciences Gets FDA Clearance For Phase 3 Acne Study
(RTTNews) - Sagimet Biosciences Inc. (SGMT), a clinical-stage biopharmaceutical company, on Thursday said it has received clearance from the U.S. Food and Drug Administration (FDA) for a Phase 3 study...
Belite Bio Q2 Net Loss Widens; FDA Sets PDUFA Date For Tinlarebant In February 2027
(RTTNews) - Belite Bio, Inc (BLTE), a clinical-stage drug development company, announced its financial results for the second quarter, reflecting a wider net loss.
SPRO Looks 14.8% Overvalued on GF Value⢠as FDA Approval Spurs Interest
SPRO Looks 14.8% Overvalued on GF Value⢠as FDA Approval Spurs Interest
Exelixis (EXEL) Q2 2026 Earnings Call Transcript
Cabozantinib revenue grew 10%, while zanzalintinib advances toward FDA decision in December.
Inovio (INO) Q2 2026 Earnings Call Transcript
INO-3107 advances toward October FDA decision as company extends cash runway through early 2027.
OraSure (OSUR) Q2 2026 Earnings Call Transcript
Revenue beat guidance at $30.6M, but IntelliQ CT/NG FDA clearance delayed to 2027.
Revolution Medicines (RVMD) Q2 2026 Earnings Call Transcript
Biotech advances RAS-inhibitor pipeline with $3.9B cash and FDA acceptance of daraxonrasib NDA.
Arbutus Advances Imdusiran; FDA Aligns On Phase 2b Trial Design
(RTTNews) - Arbutus Biopharma Corporation (ABUS), a clinical-stage biopharmaceutical company focused on infectious diseases, reported second-quarter 2026 financial results and corporate updates, highl...
FDA raids reach corridors of power: Teams seal canteens at Vidhana Soudha, health dept
Karnataka FDA raids govt canteens at Arogya Soudha and Vidhana Soudha, flags hygiene lapses; issues notice to Zomato Hyperpure warehouse over violations.
PolyPid Advances D-PLEX100; FDA Grants Priority Review
(RTTNews) - PolyPid Ltd. (PYPD), an innovative biopharmaceutical company developing long-acting, controlled-release therapies, reported second-quarter 2026 financial results and corporate updates, hig...
Xilio Advances XTX501; FDA Clears IND For Phase 1/2 Trial
(RTTNews) - Xilio Therapeutics, Inc. (XLO), a clinical-stage biotechnology company developing masked immuno-oncology therapies, reported second-quarter 2026 financial results and business updates, hig...
Maharashtra FDA suspends licences of 4 outlets of pizza chain, including three in Mumbai
Maharashtra FDA suspended licences of four Domino’s outlets, including three in Mumbai, amid statewide inspections citing severe hygiene lapses and violations.
Freenome's SimpleScreen Lung Receives FDA Breakthrough Device Designation
(RTTNews) - Freenome, Inc. (FRNM), an early cancer detection company developing blood-based screening tests, announced that the U.S. FDA granted Breakthrough Device Designation to its investigational ...
Maharashtra FDA suspends licences of 4 outlets of leading pizza chain over food safety violations
Maharashtra FDA suspended licenses of four Domino's Pizza outlets for hygiene violations. Action was taken against outlets in Mumbai and Satara districts. Inspections revealed deficiencies in cleanlin...
Can-Fite Advances Phase III Programs; Namodenoson Retains FDA Fast Track Status
(RTTNews) - Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing small-molecule therapies for oncological and inflammatory diseases, provided an update on the regulatory s...
Expired food at health dept HQ, cockroaches in Vidhana Soudha: FDA's Bengaluru crackdown widens
Food safety officials inspected government canteens, finding expired products and unhygienic storage. Expired idli rava and coconut powder were discovered at Arogya Soudha's canteen. A canteen at Vika...
Raiding Court Canteen To Razing Dawood's 'Palace': Officers Who Took On Power
Since taking over as Commissioner of the Food and Drug Administration (FDA) three months ago, Mundhe has put the state's entire food and beverage industry on edge.
Dr. Scott Gottlieb on Trump’s vaccine EO: Expect an increase in divide between red and blue states
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss President Trump's executive order on vaccination schedule for children in the U.S., concerns over food safety, and more.
Food safety officials find labelling, storage lapses at Zomato Hyperpure unit
A recent FDA inspection at Zomato's Hyperpure unit in Bengaluru Rural revealed significant food safety concerns. The officials flagged issues with product labeling, proper licensing, and storage pract...
We’ll go everywhere there is food, says Karnataka’s FDA commissioner
Karnataka food safety commissioner K Srinivas says inspections will expand from roadside eateries to star hotels, cloud kitchens and caterers, citing major hygiene gaps and new state licensing powers.
FDA suspends licences of 12 Pune, Sangli outlets
Maharashtra FDA suspends 12 Pune & Sangli food licences; seizes ₹41.38 lakh banned items, arrests 24, seals 14 units; 598 kg mava seized in Pune.
Arvinas (ARVN) Q2 2026 Earnings Call Transcript
VEPPANU's FDA approval and $50 million Pfizer milestone fuel record net income.
Mega blood donation drive on Aug 15
Mega blood donation camp in Belagavi on Aug 15 at Mahaveer Bhavan (8am–3pm), hosted by JITO with FDA; donors get Rs 1 lakh accident cover.
Palvella (PVLA) Q2 2026 Earnings Call Transcript
Rare skin disease biotech reports $250.6M cash, plans 2027 FDA approval for lead therapy.
Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines
The Bombay High Court urged the Maharashtra FDA to act judiciously concerning Cadila Pharmaceuticals' medicine ban. The court questioned the regulator's drastic actions before conducting proper inquir...